Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
All content for Dangerous Ideas In Drug Development is the property of NSW Early Phase Clinical Trials Alliance (NECTA) and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
In our latest episode we're joined by Etira, a company exploring a novel mechanism of inducing targeted ER stress in cancer. Learn with us about how LIPA is targeted to generate anticancer effects with prospects across many cancers.
Dangerous Ideas In Drug Development
Join our hosts from the NSW Early Phase Clinical Trials Alliance as they interview guests from across the early drug development industry. We'll be discussing the latest novel agents that are breaking ground in oncology around the world.
